These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9496536)
1. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas. Fujiwara K; Ikeda H; Yoshimoto T Clin Neuropathol; 1998; 17(1):19-26. PubMed ID: 9496536 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas. Ikeda H Brain Tumor Pathol; 2006 Apr; 23(1):7-12. PubMed ID: 18095113 [TBL] [Abstract][Full Text] [Related]
3. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells. de Jonge RR; Garrigue-Antar L; Vellucci VF; Reiss M Oncol Res; 1997; 9(2):89-98. PubMed ID: 9167190 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
5. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526 [TBL] [Abstract][Full Text] [Related]
6. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of TGF-beta-receptor type II in human pituitary adenomas. Fujiwara K; Ikeda H; Yoshimoto T Acta Histochem; 1995 Oct; 97(4):445-54. PubMed ID: 8607295 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Shin KH; Park YJ; Park JG Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536 [TBL] [Abstract][Full Text] [Related]
9. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction. Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer. Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
12. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304 [TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study. Cardillo MR; Yap E J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902 [TBL] [Abstract][Full Text] [Related]
14. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas]. Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154 [TBL] [Abstract][Full Text] [Related]
17. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line. Park B; Jang JS; Park K Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386 [TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta receptor II mRNA in cyclosporine-induced gingival overgrowth. Stefanidou V; Liakopoulos V; Eleftheriadis T; Anifandis G; Mertens PR; Kanelaki E; Stefanidis I Transplant Proc; 2006 Nov; 38(9):2905-8. PubMed ID: 17112860 [TBL] [Abstract][Full Text] [Related]
19. Molecular cloning, genetic mapping, and developmental expression of a bovine transforming growth factor beta (TGF-beta) type I receptor. Roelen BA; Van Eijk MJ; Van Rooijen MA; Bevers MM; Larson JH; Lewin HA; Mummery CL Mol Reprod Dev; 1998 Jan; 49(1):1-9. PubMed ID: 9406190 [TBL] [Abstract][Full Text] [Related]
20. Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis. Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB Mol Carcinog; 2004 Aug; 40(4):212-31. PubMed ID: 15264213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]